RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DAPAVO P
Collezione AOU Novara

Items : 6

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2025 Mar;39 Suppl 1:7-14. doi: 10.1111/jdv.20187. Epub 2024 Jun 26.

2025
AOU Novara

Bonifati C; Lembo S; Richetta AG; Romanelli M; Satolli F; Corazza M; Atzori L; Lasagni C; Potenza C; Savoia P; Bardazzi F; Di Lernia VG; Bianchi L; Fabbrocini G; Giofrè C; Zichichi L; Guarneri C; Pallotta S; Fargnoli MC; Loconsole F; Offidani A; Burlando M; Piaserico S; Peris K; Papini M; Carrera CG; Costanzo A; Prignano F; Bongiorno MR; et alii...

Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence. in Dermatology and therapy / Dermatol Ther (Heidelb). 2024 Oct;14(10):2739-2757. doi: 10.1007/s13555-024-01255-4. Epub 2024 Sep 2

2024
AOU Città della Salute di Torino
AOU Novara

Stingeni L; Savoia P; Romanelli M; Prignano F; Potenza C; Piaserico S; Pellacani G; Parodi A; Palazzo G; Offidani AM; Morrone P; Mercuri SR; Mazzocchetti G; Loconsole F; Lembo S; Guarneri C; Gisondi P; Giofrè C; Fargnoli MC; Congedo M; Chiricozzi A; Cattaneo A; Bianchi L; Bardazzi F; Balato A; Atzori L; Amerio P; Dapavo P; Malagoli P; et alii...

Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22.

2022
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
AOU Novara

Ribero S; Dapavo P; Quaglino P; Graziola F; Merlo G; Mocci L; Pella P; Giura MT; Rossotto G; Peila R; Leporati C; Addese C; Baggini G; Aragone MG; Pertusi G; Solaroli C; Licciardello M; Cariti C; Macagno N; Boskovic S; Castelli F; Stroppiana E; Passerini SG; Susca S; Ortoncelli M; Verrone A; Tiberio R; Mastorino L;

Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2021 Mar;35(3):693-700. doi: 10.1111/jdv.16931. Epub 2020 Oct 13.

2021
ASL Vercelli
AOU Novara

Gattoni M; Cusano F; Bardazzi F; Pella P; Loconsole F; Lo Schiavo A; Gisondi P; Argenziano G; Offidani AM; Dastoli S; Tiberio R; Rossi M; Parodi A; Dapavo P; Esposito M; Fargnoli MC; Nacca M; Cannavò SP; Pellegrini C; Costanzo A;

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2021 Feb;21(2):271-277. doi: 10.1080/14712598.2021.1853698. Epub 2021 Jan 13.

2021
AOU Novara

Talamonti M; Galluzzo M; Chiricozzi A; Quaglino P; Fabbrocini G; Gisondi P; Marzano AV; Potenza C; Conti A; Parodi A; Piaserico S; Bardazzi F; Argenziano G; Rongioletti F; Stingeni L; Micali G; Loconsole F; Rossi MT; Bongiorno MR; Feliciani C; Rubegni P; Amerio P; Fargnoli MC; Pigatto P; Savoia P; Nisticò SP; Giustini S; Carugno A; Cannavo' SP; et alii...

Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations. in Dermatology and therapy / Dermatol Ther (Heidelb). 2021 Feb;11(1):235-252. doi: 10.1007/s13555-020-00475-8. Epub 2021 Jan 11.

2021
AOU Novara

Gisondi P; Talamonti M; Chiricozzi A; Piaserico S; Amerio P; Balato A; Bardazzi F; Calzavara Pinton P; Campanati A; Cattaneo A; Dapavo P; De Simone C; Dini V; Fargnoli MC; Flori ML; Galluzzo M; Guarneri C; Lasagni C; Loconsole F; Lo Schiavo A; Malagoli P; Malara G; Mercuri SR; Musumeci ML; Naldi L; Papini M; Parodi A; Potenza C; Prignano F; et alii...